Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

Clinical trial NCT02867709 · COMPLETED

Trial details

NCT number: NCT02867709
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Migraine, With or Without Aura

Start date: 2016-08-26
Primary completion: 2018-01-25
Enrollment: 1686

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.